Keratinocyte growth factor (KGF), a member of the fibroblast growth factor (FGF) family, was identified as a specific keratinocyte mitogen after isolation from a lung fibroblast line. Recently, recombinant (r)KGF was found to influence proliferation and differentiation patterns of multiple epithelial cell lineages within skin, lung, and the reproductive tract. In the present study, we designed experiments to identify additional target tissues, and focused on the rat gastrointestinal (GI) system, since a putative receptor, K-sam, was originally identified in a gastric carcinoma. Expression of KGF receptor and KGF mRNA was detected within the entire GI tract, suggesting the gut both synthesized and responded to KGF. Therefore, rKGF was administered to adult rats and was found to induce markedly increased proliferation of epithelial cells from the foregut to the colon, and of hepatocytes, one day after systemic treatment. Daily treatment resulted in the marked selective induction of mucin-producing cell lineages throughout the GI tract in a dose-dependent fashion. Other cell lineages were either unaffected (e.g., Paneth cells), or relatively decreased (e.g., parietal cells, enterocytes) in rKGF-treated rats. The direct effect of rKGF was confirmed by demonstrating markedly increased carcinoembryonic antigen production in a human colon carcinoma cell line, LIM1899. Serum levels of albumin were specifically and significantly elevated after daily treatment. These results demonstrate rKIGF can induce epithelial cell activation throughout the GI tract and liver. Further, endogenous KGF may be a normal paracrine mediator of growth within the gut. (J. Clin. Iptvqst. 1994Iptvqst. . 94:1764Iptvqst. -1777 
Introduction
Keratinocyte growth factor (KGF/FGF-7) was initially purified and cloned from a lung fibroblast line as a soluble factor which carcinoembryonic antigen; HGF, hepatocyte growth factor; PAS, periodic-acid-Schiff; rKGF, recombinant keratinocyte growth factor. could stimulate keratinocyte proliferation by Rubin, Finch, and co-workers (1, 2) . Although other members of the FGF and epidermal growth factor (EGF) families also stimulate keratinocytes, KGF was shown to be a more potent mitogen as well as a more potent differentiation agent in vitro (3) . A direct role for KGF in keratinocyte proliferation was suggested by Werner and co-workers (4) in experiments using rodent dermal wounds, where KGF mRNA expression was observed to increase over 100-fold 1 d after wounding. Studies by Miki et al. (5, 6) revealed that the basis for KGF selectivity was specific binding to a splice variant of FGF receptor 2 (FGFR2, bek), which is similar to K-sam, an activated receptor found in a gastric carcinoma cell line (7) . Multiple other cell types examined, including endothelial cells, smooth muscle cells, and fibroblasts, which respond to other FGF family members, do not express the KGF receptor variant of FGFR2, and hence do not bind KGF (2).
Although KGF was thought to be an endogenous paracrine effector of keratinocyte growth in skin, it was originally isolated from a human lung fibroblast line and rat lung tissue was found to contain high levels of KGF and KGF receptor message (1, 2, 8) . Expression of the KGF transcript also has been detected in several stromal fibroblast cell lines derived from epithelial tissues of embryonic, neonatal, and adult human sources (2). KGF mRNA has not been detected in glial cells, brain nor in a variety of epithelial cell lines (2). In vivo, rKGF was found to induce proliferation of hair follicles, sebaceous glands, and regenerating keratinocytes within rabbit dermal wounds (9) , and to influence basement membrane maturation in porcine wounds (10). Recently, rKGF was shown to induce proliferation of type II pneumocytes in vitro and in vivo (8, 11) . In vivo, increased surfactant was found in the lungs of rats treated with rKGF (8) . rKGF has also been shown to stimulate pancreatic ductal epithelia, mammary gland ductal epithelia, and to mediate androgen action in androgen-dependent epithelia such as the prostate and seminal vesicles (12) (13) (14) (15) .
Taken together, these observations imply that KGF is an endogenous paracrine effector for a variety of epithelial cells that is synthesized by underlying stromal fibroblasts. However, little information is available on the potential for KGF to influence epithelial tissues in the liver and gastrointestinal tract. The present results indicate that KGF is likely an important endogenous mediator of cell growth and differentiation in the gastrointestinal tract and liver, and that administration of pharmacologic amounts of rKGF has a highly significant inductive effect on specific epithelial lineages within these organs.
A YEAST (-contro) BalbdMK ( er's protocols (Ciba-Coming, Coming, NY). For alkaline phosphatase isoenzyme determination, positive controls included homogenates of liver, bone, and intestine. Carcasses were perfused through the left ventricle with 4% paraformaldehyde (Sigma Chemical Co., St. Louis, MO) using a peristaltic pump (Watson-Marlow Inc., Wilmington, MA). Major organs were weighed in a blinded fashion and weights were expressed as grams per 100 g body weight (percent body weight). The gut was divided into the esophagus, nonglandular foregut, glandular stomach, duodenum, jejunum, ileum, and proximal and distal colon. Tissue samples were fixed in 10% buffered formalin or 4% paraformaldehyde overnight for routine histological processing or in 2-methylbutane cooled by liquid nitrogen following embedding in OCT (Miles Inc., Elkhart, IN) for immunohistochemical, fat and carbohydrate staining. For RNase protection assays, tissues were immediately frozen on dry ice and stored at -70'C until use.
RNA isolation and RNase protection assay
Total RNA was isolated from 1 g rat tissue as described by Chomczynski and Sacchi (17) . For RNase protection mapping of KGFR and KGF transcripts, DNA probes were cloned into transcription vectors pGEM4Z and pSP72 (Promega, Madison, WI), respectively. The rat KGF antisense transcript used corresponds to nucleotides 132 to 336 (18) . The KGFR antisense transcript used corresponds to nucleotides 1270 to 1417 (5) . This region of KGFR sequence was determined to be identical in mouse and rat (Biltz, R., unpublished data). villus height, and colonic crypt depth in the proximal colon were measured. To quantify the changes in goblet cell production the number of PAS positive goblet cells was counted along 100 Jsm lengths beginning at the base of the duodenal villi. In addition, the number of colonic crypts and the number of hyperplastic (bifurcated or trifurcated crypts) occupying a 100 /um length of colonic mucosa were determined. In all areas of the gut, measurements were made only on glands or villi that appeared perpendicular to the underlying muscularis. 5-10 replicate measurements were made per animal and averaged.
Statistical analyses. All quantifiable data were analyzed using an unpaired two-tailed Student's t test or one-way analysis of variance (ANOVA) for multiple group comparisons, followed by BonferoniDunn post-hoc analyses (Statview IV; Abacus Concepts, Berkeley, CA). Data are presented as mean±standard error of the mean (SE).
Immunohistochemistry of cultured LIM1899 cells. The LIM1899 colon carcinoma cell line was maintained as previously described (20) . Cells were grown directly on Lab-Tek Chamber Slides (Lab-Tek Products, Inc., Naperville, IL) in RPMI 1640 containing 5% fetal bovine serum in the presence or absence of 20 ng/ml rKGF for 5 d. Cultures were washed with PBS, fixed with cold absolute acetone for 15 min and stained by indirect immunofluorescence using an IgM monoclonal antibody (mAb) 4E7, which recognizes an epitope on CEA, and fluorescein isothiocyanate-conjugated sheep anti-mouse IgG (Cappel, Inc., Arlington Heights, IL). mAb 4E7 was raised against the LS174T colon carcinoma cell line and shows similar staining on tissues and Western blots as CEA specific polyclonal antibodies (Devine, P.L., unpublished observation).
Immunochemical detection of CEA and related proteins. LIM1899 cells were cultured for 6 d in the presence or absence of 50 ng/ml rKGF. Media was collected for CEA immunoassays and Western blotting. Cells were harvested, solubilized in 1% sodium dodecyl sulfate (SDS), and extracts were Western blotted after separation on 3-15% gradient SDS-PAGE (21) . mAb 4E7 was used to probe Western blots of cells and culture supernatant for the presence of CEA. A multi-determinant enzyme-linked immunoassay (ELISA) was performed on supernatants using 4E7-coated microtiter plates to capture antigen and rabbit polyclonal anti-human CEA (Dakopatts, Glostrup, Denmark) to detect bound antigen, followed by detection with anti-rabbit Ig-peroxidase (Silenus, Melbourne, Australia) as described (22) . The IMx CEA microparticle enzyme immunoassay (Abbott Labs, Abbott Park, IL) was also used to quantify CEA levels in supernatants which had been concentrated fourfold in a 10,000 molecular weight cutoff centrifugal concentrator (Amicon, Beverley, MA).
Results
RNase protection assay. Both KGF receptor mRNA and KGF mRNA were detected in the gut of normal rats (Fig. 1) . In most tissues examined, KGF receptor mRNA expression was 1766 Housley et al. (Table II) . Alkaline phosphatase was significantly reduced by 4 d treatment with rKGF. When alkaline phosphatase isoenzymes were fractionated electrophoretically, the decrease could be accounted for almost entirely by diminished enterocyte-produced intestinal isoenzyme. No change in serum bilirubin was observed in rKGF-treated rats. The rapid increase of serum triglycerides and cholesterol beginning after 1 d rKGF treatment, indicated an influence on fat metabolism. The increased cholesterol levels were due to increased HDL and LDL fractions. The HDL/total cholesterol ratio was 0.6 in both rKGF-treated and control rats. The serum transaminases, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) were minimally elevated (data not shown).
Blood urea nitrogen (BUN) and creatinine (data not shown) were similar in controls and rKGF-treated rats (Table II) . These observations, coupled with no changes in body weights or hematocrits between groups suggested that hemoconcentration due to dehydration was not the cause of elevated serum proteins. The elevated serum proteins were subjected to high resolution electrophoresis. Sera from rKGF-treated animals showed only increased levels of albumin compared to controls. The albumin peak accounted for 60±4% of the total protein on rKGF-treated animals on day 7, compared with 49±4% in controls. Other peaks showed no differences in protein content between groups (data not shown).
Hepatocyte proliferation. Liver weight was increased after as little as 1 d of rKGF treatment (Table II) . A corresponding marked increase in hepatocyte proliferation was detected to 6-8-fold above controls, peaking after 1 d of rKGF treatment (Figs. 2 and 3 ). While hepatic hyperplasia was observed, hepatocyte hypertrophy was not detected in rKGF-treated rats, and hepatocyte density per unit area remained similar between the two groups (rKGF 879±11 vs. 821±27), suggesting increased numbers of hepatocytes were responsible for the increased liver weight. At day 7, mild biliary duct hyperplasia was present in treated animals. Taken together, the results in the liver suggest the burst of proliferation resulted in more protein-secreting differentiated hepatocytes.
Esophagus and stomach proliferation and differentiation. The foregut and glandular stomach, which contain KGF receptor mRNA, showed significant weight increases after 4 and 7 d treatment (Table I) . Despite detecting KGF receptor mRNA, the esophagus was histologically normal and proliferation was not increased after rKGF treatment (Fig. 4, A and B) . The oral cavity was also unresponsive to rKGF. The mucosal surface epithelium of the esophagus changed abruptly at the cardia to the proliferative epithelium of the rKGF-treated foregut. At 4 d, the foregut epithelium was mildly thickened with a rete peglike appearance of skin, overlaying a normal appearing lamina propria. At 7 d, the thickened keratinized epithelium covered polyp-like projections of lamina propria that extended up from the underlying muscularis into the lumen (Fig. 4, C and D) . At markedly widened with numerous BrdU positive proliferating cells and displaced toward the serosal surface (Fig. 4, E-H) . By 4 and 7 d of rKGF treatment, increased numbers of gastric pit mucin-producing cells were detected throughout the glandular gastric mucosa (Figs. 4, I-L) . A corresponding decrease in the number of parietal cells also was observed in rKGF-treated rats. Animals treated with rKGF for 4 and 7 d had mildly elongated gastric glands (Fig. 5 A) . The depth of the mucous layer from the luminal surface of the gastric mucosa was also markedly increased after 4 (P = 0.0004) and 7 (P = 0.001) days rKGF treatment (Fig. 5 B) . Mucin appeared qualitatively normal. More mature mucin-producing gastric pit cells approaching the lumen no longer proliferated (Fig. 4, E-H) . Small intestinal tract proliferation and differentiation. The small intestine appeared grossly normal at all study points. The depth of duodenal crypts was significantly increased beginning after 1 d of treatment (Fig. 6 A) . Markedly increased numbers of mucus producing goblet cells within crypts and villi were detected after 4 and 7 d of rKGF treatment (Figs. 6 B and 7) . Villus heights were not increased in rKGF-treated rats, suggesting that the increased numbers of cells contained within crypts may have accelerated transit times through villi.
Colon proliferation and differentiation. The net weight of the colon was increased at days 4 and 7 in rKGF-treated rats (Table I) . By 7 d, the proximal colonic mucosa developed rugallike folds that greatly increased the overall surface area. Bifurcated and trifurcated colonic crypts, which indicate crypt fission, were most prominent after 1 d rKGF treatment (Figs. 8 A and  9, A and B) . There was no difference in the total number of crypts per unit area at any treatment time point (data not shown). The depth of colonic crypts increased after 7 d (Fig. 8 B) . The distal colon also demonstrated similar hyperplastic changes.
A dramatic increase in mucus producing goblet cells throughout the proximal and distal colon was detected in rKGFtreated rats using Alcian blue stain (Fig. 9, C and D) . In controls the number of goblet cells decreased toward the luminal surface (Table II) . Paneth cells, located at the base of crypts in the small intestine, did not appear to change in number with rKGF treatment, using lysozyme as a marker. Enteroendocrine cells, the fourth major cell type in the gut, were rare in both rKGFtreated and control animals, using serotonin as a marker. Taken together, these observations suggest the finding of more goblet cell-specific lineage stimulation by rKGF.
Immunodetection of carcinoembryonic antigen in the colon carcinoma cell line LIM1899. Immunofluorescent analysis of LIM 1899 cells using 4E7 antibody, which identifies CEA, demonstrated markedly increased numbers of positive cells and intensity of fluorescence in rKGF-treated, compared with control cell cultures (Fig. 10, A and B) . Western blotting of LIM1899 cell extracts and conditioned medium using 4E7 and anti-CEA (data not shown) confirmed the specific induction of CEA synthesis in rKGF-treated cells (Fig. 1 1) . Furthermore, the reactivity of a large panel of anti-mucin monoclonal antibodies (22) was unaffected by rKGF treatment, confirming the specific induction of CEA (data not shown). A multi-site ELISA, in which 4E7 was used to capture CEA and polyclonal anti-CEA was used for detection, demonstrated a fourfold increase in secreted CEA from rKGF-treated cells (dilution for OD405 nm = 0.5 was 1/8 for the untreated culture and 1/32 for the KGF-treated culture). These results were further demonstrated using the Abbott CEA immunoassay, where rKGF-treated culture supernatant contained 233 ng/ml CEA, compared with 94 ng/ml CEA in untreated culture supernatant. Although the degree of stimulation varied with the assay and antibodies used for detection of CEA, rKGF specifically induced markedly increased CEA in all assays.
Transience ofrKGF-induced changes. A washout study was (24) . Finding bile duct hyperplasia and pancreatic ductal hyperplasia (12) also in rKGF-treated rats is consistent with their shared lineage with hepatocyte precursors.
Other epithelial cell mitogens, including epidermal growth factor (EGF)/transforming growth factor a (TGF-a), acidic fibroblast growth factor (aFGF), and hepatocyte growth factor (HGF) stimulate hepatocyte proliferation in vitro, and after partial hepatectomy or other forms of liver injury (25) (26) (27) (28) (29) (30) . Recently, rKGF has been found to be mitogenic for cultured rat hepatocytes (31, 32 tered to animals had minimal effects on DNA synthesis in intact livers, in contrast to the marked effects observed with rKGF in the present study. KGF and the gastric mucosa. The mechanisms behind the massive proliferation of the foregut with apparent sparing of the esophagus are unknown, since KGF receptor message was detected in both tissues. These two tissues are histologically similar in appearance and respond similarly to EGF administered to mice (33) . The present results suggest the nonglandular foregut, which is not present in humans, is distinct from the esophagus.
rKGF induced the marked expansion of progenitor cells in the isthmus above the mucus neck layer of the glandular stomach. Similarly, EGF, TGFa, and HGF stimulate proliferation in the gastric mucosa in vitro (34) (35) (36) (38) (39) (40) . rKGF induced elongation of crypts and specifically increased goblet cell differentiation on the villi. The rKGF targets in the crypts have not yet been identified, and may be either multipotential progenitors (stem cells) or specific goblet cell precursors (41) .
Enterocytes normally comprise the bulk of the epithelial cells covering the small intestinal villi (42), yet were eclipsed by goblet cells in rKGF-treated villi, findings which are directly supported by finding diminished serum alkaline phosphatase of intestinal origin. rKGF does not appear to influence Paneth and enteroendocrine cells. Experiments using chimeric transgenic mice over-expressing specific markers for the differentiated cell types within the small intestine (41) (42) (43) should be useful in more precisely identifying rKGF targets.
In the large intestine early crypt hyperplasia was followed by crypt elongation in rKGF-treated animals. The mechanisms of new crypt generation are not understood but are thought to involve budding from pre-existing crypts (fission). rKGF may be targeting a stem cell population capable of not only elongating crypts and increasing goblet cell differentiation, but of generating new crypts as well (44) . The relative diminution in enterocytes detected in the small intestine also was observed in the colon of rKGF-treated animals.
CEA is a member of the immunoglobulin superfamily which mediates cell adhesion, and has been identified in normal colonic epithelial cells and in most colon carcinomas (20, 45, 46) . Differentiation inducers such as sodium butyrate have been shown to increase CEA production in colon carcinoma and adenoma cell lines, largely via increased transcription of CEA mRNA (47) . We observed specific induction of CEA in the colon carcinoma cell line LIM 1899, after treatment with rKGF. Since mucus producing goblet cells clearly are increased following rKGF treatment, these in vitro findings support the notion that goblet cell precursors are a KGF target.
Other growth factors also are capable of influencing cells in the GI tract. TGFa has been detected throughout the mucosa of the gastrointestinal tract (48, 49) as well as in intestinal epithelial and crypt derived cell lines (50) , and may be involved in the response to injury (51) (52) (53) . Although 
